The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Wendy K. Alderton Paul A Clarke Marketa J Zvelebil Laurent Salphati Paul Workman |
| Publication date | September 25, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |